Journal
CELLULAR SIGNALLING
Volume 104, Issue -, Pages -Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cellsig.2022.110580
Keywords
Radioresistant gene; Cancer; Radiotherapy; Apoptosis; MicroRNA; Radiosensitivity
Categories
Ask authors/readers for more resources
Resistance to cancer radiotherapy is a major obstacle in successful treatment and prevention of recurrent disease. MicroRNAs play a crucial role in predicting prognosis, distinguishing cancer subtypes, and influencing treatment outcomes. Constraining these microRNAs could be an effective strategy to overcome radiation resistance.
Resistance to cancer radiotherapy is one of the biggest concerns for success in treating and preventing recurrent disease. Malignant tumors may develop when they block genetic mutations associated with apoptosis or abnormal expression of apoptosis; Tumor treatment may induce the expression of apoptosis-related genes to promote tumor cell apoptosis. MicroRNAs have been shown to contribute to forecasting prognosis, distinguishing between cancer subtypes, and affecting treatment outcomes in cancer. Constraining these miRNAs may be an attractive treatment strategy to help overcome radiation resistance. The delivery of these future treatments is still challenging due to the excess downstream targets that each miRNA can control. Understanding the role of miRNAs brings us one step closer to attaining patient treatment and improving patient outcomes. This review summarized the current information on the role of microRNA-induced apoptosis in determining the radiosen-sitivity of various cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available